Home » FDA Questions Whether Avastin Benefits Breast Cancer Patients
FDA Questions Whether Avastin Benefits Breast Cancer Patients
The Food and Drug Administration said Monday that Genentech Inc.'s cancer drug Avastin didn't appear to extend overall survival of breast-cancer patients and will ask an outside panel of medical experts whether the drug should be approved as a breast-cancer treatment.
The Wall Street Journal Online
The Wall Street Journal Online
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May